{"name":"Boehringer Ingelheim","slug":"boehringer","ticker":"Private","exchange":"Private","domain":"boehringer-ingelheim.com","description":"C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one.","hq":"Ingelheim am Rhein, Germany","founded":0,"employees":"","ceo":"Hubertus von Baumbach","sector":"Diversified Pharma / Diabetes / Respiratory / Oncology","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"Private (~€55B estimated enterprise value)","metrics":{"revenue":26800000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[{"name":"Jardiance","genericName":"empagliflozin","slug":"empagliflozin","revenue":6500000000,"yoyGrowth":0,"percentOfTotal":44.8},{"name":"Spiriva","genericName":"TIOTROPIUM BROMIDE","slug":"tiotropium-bromide","revenue":2500000000,"yoyGrowth":0,"percentOfTotal":17.2},{"name":"Ofev","genericName":"NINTEDANIB","slug":"nintedanib","revenue":2000000000,"yoyGrowth":0,"percentOfTotal":13.8},{"name":"Dabigatran Etexilate","genericName":"DABIGATRAN","slug":"chembl-chembl48361","revenue":1200000000,"yoyGrowth":0,"percentOfTotal":8.3},{"name":"Tradjenta","genericName":"LINAGLIPTIN","slug":"linagliptin","revenue":800000000,"yoyGrowth":0,"percentOfTotal":5.5},{"name":"Tradjenta","genericName":"BI 1356","slug":"bi-1356","revenue":800000000,"yoyGrowth":0,"percentOfTotal":5.5},{"name":"Gilotrif","genericName":"afatinib","slug":"afatinib","revenue":400000000,"yoyGrowth":0,"percentOfTotal":2.8},{"name":"Spevigo","genericName":"SPESOLIMAB","slug":"spesolimab","revenue":300000000,"yoyGrowth":0,"percentOfTotal":2.1}],"timeline":[{"date":"1961-01-01","label":"Persantine first approved","drug":"Persantine","drugSlug":"dipyridamole","type":"approval","sentiment":"positive"},{"date":"1985-01-01","label":"Mexitil first approved","drug":"Mexitil","drugSlug":"mexiletine","type":"approval","sentiment":"positive"},{"date":"1996-01-01","label":"Verluma first approved","drug":"Verluma","drugSlug":"technetium-99mtc-nofetumomab-merpentan","type":"approval","sentiment":"positive"},{"date":"1996-01-01","label":"Viramune first approved","drug":"Viramune","drugSlug":"nevirapine","type":"approval","sentiment":"positive"},{"date":"1998-01-01","label":"Micardis first approved","drug":"Micardis","drugSlug":"telmisartan","type":"approval","sentiment":"positive"},{"date":"2000-01-01","label":"Mobic first approved","drug":"Mobic","drugSlug":"meloxicam","type":"approval","sentiment":"positive"},{"date":"2004-01-01","label":"Spiriva first approved","drug":"Spiriva","drugSlug":"tiotropium-bromide","type":"approval","sentiment":"positive"},{"date":"2011-01-01","label":"Tradjenta first approved","drug":"Tradjenta","drugSlug":"linagliptin","type":"approval","sentiment":"positive"},{"date":"2011-01-01","label":"Tradjenta first approved","drug":"Tradjenta","drugSlug":"bi-1356","type":"approval","sentiment":"positive"},{"date":"2013-01-01","label":"Gilotrif first approved","drug":"Gilotrif","drugSlug":"afatinib","type":"approval","sentiment":"positive"},{"date":"2014-01-01","label":"Jardiance first approved","drug":"Jardiance","drugSlug":"empagliflozin","type":"approval","sentiment":"positive"},{"date":"2014-01-01","label":"Ofev first approved","drug":"Ofev","drugSlug":"nintedanib","type":"approval","sentiment":"positive"},{"date":"2014-01-01","label":"Striverdi Respimat first approved","drug":"Striverdi Respimat","drugSlug":"olodaterol","type":"approval","sentiment":"positive"},{"date":"2015-01-01","label":"Praxbind first approved","drug":"Praxbind","drugSlug":"idarucizumab","type":"approval","sentiment":"positive"},{"date":"2022-01-01","label":"Spevigo first approved","drug":"Spevigo","drugSlug":"spesolimab","type":"approval","sentiment":"positive"},{"date":"2025-01-01","label":"Dabigatran Etexilate first approved","drug":"Dabigatran Etexilate","drugSlug":"chembl-chembl48361","type":"approval","sentiment":"positive"},{"date":"2025-01-01","label":"Hernexeos first approved","drug":"Hernexeos","drugSlug":"zongertinib","type":"approval","sentiment":"positive"},{"date":"2025-01-01","label":"Jascayd first approved","drug":"Jascayd","drugSlug":"nerandomilast","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-10","label":"Spiriva patent expiry (Formulation)","drug":"Spiriva","drugSlug":"tiotropium-bromide","type":"patent_expiry","sentiment":"negative"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-03-31","label":"Spiriva patent expiry (Formulation)","drug":"Spiriva","drugSlug":"tiotropium-bromide","type":"patent_expiry","sentiment":"negative"},{"date":"2027-04-10","label":"Spiriva patent expiry (Compound)","drug":"Spiriva","drugSlug":"tiotropium-bromide","type":"patent_expiry","sentiment":"negative"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-01","label":"Flomax Phase 3 readout (Prostatic Hyperplasia, Benign, Erectile Dysfunction)","drug":"Flomax","drugSlug":"tamsulosin","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-09-30","label":"Spiriva patent expiry (Compound)","drug":"Spiriva","drugSlug":"tiotropium-bromide","type":"patent_expiry","sentiment":"negative"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-03-13","label":"Spiriva patent expiry (Formulation)","drug":"Spiriva","drugSlug":"tiotropium-bromide","type":"patent_expiry","sentiment":"negative"},{"date":"2028-08-30","label":"Hernexeos PHASE1 readout","drug":"Hernexeos","drugSlug":"zongertinib","type":"phase3_readout","sentiment":"neutral"},{"date":"2028-09-13","label":"Spiriva patent expiry (Compound)","drug":"Spiriva","drugSlug":"tiotropium-bromide","type":"patent_expiry","sentiment":"negative"},{"date":"2029-03-12","label":"Viramune patent expiry (Method of Use)","drug":"Viramune","drugSlug":"nevirapine","type":"patent_expiry","sentiment":"negative"},{"date":"2029-07-01","label":"Actilyse Phase 3 readout (Stroke, Acute Ischemic)","drug":"Actilyse","drugSlug":"actilyse","type":"phase3_readout","sentiment":"neutral"},{"date":"2030-05-26","label":"Mobic patent expiry (Method of Use)","drug":"Mobic","drugSlug":"meloxicam","type":"patent_expiry","sentiment":"negative"},{"date":"2030-05-26","label":"Mobic patent expiry (Formulation)","drug":"Mobic","drugSlug":"meloxicam","type":"patent_expiry","sentiment":"negative"},{"date":"2030-05-26","label":"Mobic patent expiry (Formulation)","drug":"Mobic","drugSlug":"meloxicam","type":"patent_expiry","sentiment":"negative"},{"date":"2030-08-31","label":"Mobic patent expiry (Formulation)","drug":"Mobic","drugSlug":"meloxicam","type":"patent_expiry","sentiment":"negative"},{"date":"2030-10-16","label":"Spiriva patent expiry (Formulation)","drug":"Spiriva","drugSlug":"tiotropium-bromide","type":"patent_expiry","sentiment":"negative"},{"date":"2031-04-16","label":"Spiriva patent expiry (Compound)","drug":"Spiriva","drugSlug":"tiotropium-bromide","type":"patent_expiry","sentiment":"negative"},{"date":"2033-03-31","label":"Mobic patent expiry (Formulation)","drug":"Mobic","drugSlug":"meloxicam","type":"patent_expiry","sentiment":"negative"},{"date":"2035-03-31","label":"Mobic patent expiry (Method of Use)","drug":"Mobic","drugSlug":"meloxicam","type":"patent_expiry","sentiment":"negative"},{"date":"2035-03-31","label":"Mobic patent expiry (Formulation)","drug":"Mobic","drugSlug":"meloxicam","type":"patent_expiry","sentiment":"negative"},{"date":"2039-03-08","label":"Mobic patent expiry (Method of Use)","drug":"Mobic","drugSlug":"meloxicam","type":"patent_expiry","sentiment":"negative"},{"date":"2039-03-08","label":"Mobic patent expiry (Method of Use)","drug":"Mobic","drugSlug":"meloxicam","type":"patent_expiry","sentiment":"negative"},{"date":"2040-07-19","label":"Mobic patent expiry (Compound)","drug":"Mobic","drugSlug":"meloxicam","type":"patent_expiry","sentiment":"negative"},{"date":"2041-07-31","label":"Mobic patent expiry (Formulation)","drug":"Mobic","drugSlug":"meloxicam","type":"patent_expiry","sentiment":"negative"},{"date":"2030-06-01","label":"Jardiance patent cliff ($1.5B at risk)","drug":"Jardiance","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":6500000000,"percentOfTotal":44.8,"drugCount":6,"colorKey":"oncology","drugs":[{"name":"Jardiance","genericName":"empagliflozin","slug":"empagliflozin","indication":"Chronic heart failure","status":"marketed","revenue":6500000000},{"name":"Bendrofluazide","genericName":"Bendrofluazide","slug":"bendrofluazide","indication":"Hypertensive disorder","status":"marketed"},{"name":"Amlodipin","genericName":"Amlodipin","slug":"amlodipin","indication":"Angina pectoris","status":"marketed"},{"name":"Micardis","genericName":"TELMISARTAN","slug":"telmisartan","indication":"Hypertension","status":"marketed"},{"name":"Persantin","genericName":"Persantin","slug":"persantin","indication":"Atrial fibrillation","status":"phase_1"},{"name":"Persantine","genericName":"DIPYRIDAMOLE","slug":"dipyridamole","indication":"Atrial fibrillation","status":"marketed"}]},{"name":"Respiratory","slug":"respiratory","revenue":2500000000,"percentOfTotal":17.2,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"Spiriva","genericName":"TIOTROPIUM BROMIDE","slug":"tiotropium-bromide","indication":"Asthma","status":"marketed","revenue":2500000000},{"name":"Jascayd","genericName":"NERANDOMILAST","slug":"nerandomilast","indication":"Idiopathic Pulmonary Fibrosis","status":"marketed"},{"name":"Striverdi Respimat","genericName":"OLODATEROL","slug":"olodaterol","indication":"Chronic obstructive lung disease","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":2400000000,"percentOfTotal":16.6,"drugCount":4,"colorKey":"cardiovascular","drugs":[{"name":"Ofev","genericName":"NINTEDANIB","slug":"nintedanib","indication":"Idiopathic pulmonary fibrosis","status":"marketed","revenue":2000000000},{"name":"Gilotrif","genericName":"afatinib","slug":"afatinib","indication":"Non-small cell lung cancer, positive for epidermal growth factor receptor expression","status":"marketed","revenue":400000000},{"name":"Beromun","genericName":"TASONERMIN","slug":"tasonermin","indication":"Sarcoma of soft tissue","status":"marketed"},{"name":"OFEV®","genericName":"OFEV®","slug":"ofev","indication":"Idiopathic pulmonary fibrosis","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":1600000000,"percentOfTotal":11,"drugCount":3,"colorKey":"infectious","drugs":[{"name":"Tradjenta","genericName":"LINAGLIPTIN","slug":"linagliptin","indication":"Diabetes mellitus type 2","status":"marketed","revenue":800000000},{"name":"Tradjenta","genericName":"BI 1356","slug":"bi-1356","indication":"Diabetes mellitus type 2","status":"marketed","revenue":800000000},{"name":"Fenmetrazina","genericName":"PHENMETRAZINE","slug":"phenmetrazine","indication":"Obesity","status":"marketed"}]},{"name":"Other","slug":"other","revenue":1200000000,"percentOfTotal":8.3,"drugCount":85,"colorKey":"neuroscience","drugs":[{"name":"Dabigatran Etexilate","genericName":"DABIGATRAN","slug":"chembl-chembl48361","indication":"Reduction of stroke and systemic embolism risk in non-valvular AF","status":"marketed","revenue":1200000000},{"name":"Pradaxa","genericName":"dabigatran-etexilate","slug":"dabigatran-etexilate","indication":"Reduction of stroke and systemic embolism risk in non-valvular AF","status":"marketed"},{"name":"Flomax","genericName":"tamsulosin","slug":"tamsulosin","indication":"Benign prostatic hyperplasia","status":"marketed"},{"name":"Actilyse","genericName":"Actilyse","slug":"actilyse","indication":"Other","status":"discontinued"},{"name":"Aggrenox","genericName":"Aggrenox","slug":"aggrenox","indication":"Other","status":"marketed"},{"name":"BI 44847","genericName":"BI 44847","slug":"bi-44847","indication":"Other","status":"phase_1"},{"name":"Beta-blockers","genericName":"Beta-blockers","slug":"beta-blockers","indication":"Other","status":"marketed"},{"name":"Dabigatran etexilate powder","genericName":"Dabigatran etexilate powder","slug":"dabigatran-etexilate-powder","indication":"Other","status":"marketed"},{"name":"High dose of telmisartan","genericName":"High dose of telmisartan","slug":"high-dose-of-telmisartan","indication":"Other","status":"marketed"},{"name":"Maalox","genericName":"Maalox","slug":"maalox","indication":"Other","status":"marketed"},{"name":"T5: Test Product P","genericName":"T5: Test Product P","slug":"t5-test-product-p","indication":"Other","status":"phase_1"},{"name":"Volasertib, high dose, d1q3w","genericName":"Volasertib, high dose, d1q3w","slug":"volasertib-high-dose-d1q3w","indication":"Other","status":"phase_1"},{"name":"WE 941 OD tablets","genericName":"WE 941 OD tablets","slug":"we-941-od-tablets","indication":"Other","status":"phase_1"},{"name":"ipratropium plus salbutamol UDV","genericName":"ipratropium plus salbutamol UDV","slug":"ipratropium-plus-salbutamol-udv","indication":"Other","status":"marketed"},{"name":"salbutamol UDV","genericName":"salbutamol UDV","slug":"salbutamol-udv","indication":"Other","status":"marketed"},{"name":"Amlodipine 10","genericName":"Amlodipine 10","slug":"amlodipine-10","indication":"Other","status":"marketed"},{"name":"Angiotensin-Converting Enzyme Inhibitors","genericName":"Angiotensin-Converting Enzyme Inhibitors","slug":"angiotensin-converting-enzyme-inhibitors","indication":"Other","status":"marketed"},{"name":"B: BI 10773 tablet and metformin tablet","genericName":"B: BI 10773 tablet and metformin tablet","slug":"b-bi-10773-tablet-and-metformin-tablet","indication":"Other","status":"phase_1"},{"name":"BI 1005273 s.c.","genericName":"BI 1005273 s.c.","slug":"bi-1005273-s-c","indication":"Other","status":"phase_1"},{"name":"BI 10773 - single rising dose","genericName":"BI 10773 - single rising dose","slug":"bi-10773-single-rising-dose","indication":"Other","status":"phase_1"},{"name":"BI 11634 IR tablet","genericName":"BI 11634 IR tablet","slug":"bi-11634-ir-tablet","indication":"Other","status":"phase_1"},{"name":"BI 1387446 200 μg","genericName":"BI 1387446 200 μg","slug":"bi-1387446-200-g","indication":"Other","status":"phase_1"},{"name":"BI 2536 BS, intravenous","genericName":"BI 2536 BS, intravenous","slug":"bi-2536-bs-intravenous","indication":"Other","status":"phase_1"},{"name":"BI 3000202_low dose","genericName":"BI 3000202_low dose","slug":"bi-3000202-low-dose","indication":"Other","status":"phase_1"},{"name":"BI 3032950","genericName":"BI 3032950","slug":"bi-3032950","indication":"Other","status":"phase_1"},{"name":"BI 3814916","genericName":"BI 3814916","slug":"bi-3814916","indication":"Other","status":"phase_1"},{"name":"BI 44370 medium dose","genericName":"BI 44370 medium dose","slug":"bi-44370-medium-dose","indication":"Other","status":"phase_1"},{"name":"BI 653048 BS H3PO4","genericName":"BI 653048 BS H3PO4","slug":"bi-653048-bs-h3po4","indication":"Other","status":"phase_1"},{"name":"BI 671800 HEA particulate","genericName":"BI 671800 HEA particulate","slug":"bi-671800-hea-particulate","indication":"Other","status":"phase_1"},{"name":"BI 690517 formulation 2","genericName":"BI 690517 formulation 2","slug":"bi-690517-formulation-2","indication":"Other","status":"phase_1"},{"name":"BI 764198 - Formula D","genericName":"BI 764198 - Formula D","slug":"bi-764198-formula-d","indication":"Other","status":"phase_1"},{"name":"BI 765128","genericName":"BI 765128","slug":"bi-765128","indication":"Other","status":"phase_1"},{"name":"BI 894999","genericName":"BI 894999","slug":"bi-894999","indication":"Other","status":"phase_1"},{"name":"BIBV 308 SE solution","genericName":"BIBV 308 SE solution","slug":"bibv-308-se-solution","indication":"Other","status":"phase_1"},{"name":"BIBW 2948 BS for oral inhalation","genericName":"BIBW 2948 BS for oral inhalation","slug":"bibw-2948-bs-for-oral-inhalation","indication":"Other","status":"phase_1"},{"name":"BIBW 2992 high dose 6 day","genericName":"BIBW 2992 high dose 6 day","slug":"bibw-2992-high-dose-6-day","indication":"Other","status":"phase_1"},{"name":"BIBW 2992 plus TMZ","genericName":"BIBW 2992 plus TMZ","slug":"bibw-2992-plus-tmz","indication":"Other","status":"phase_2"},{"name":"BIBX 245 CL- fasted","genericName":"BIBX 245 CL- fasted","slug":"bibx-245-cl-fasted","indication":"Other","status":"phase_1"},{"name":"BIIL 284 BS low dose","genericName":"BIIL 284 BS low dose","slug":"biil-284-bs-low-dose","indication":"Other","status":"phase_2"},{"name":"BIIL 284 BS, low dose, adult patients","genericName":"BIIL 284 BS, low dose, adult patients","slug":"biil-284-bs-low-dose-adult-patients","indication":"Other","status":"phase_1"},{"name":"BIIX 1 XX - single rising dose","genericName":"BIIX 1 XX - single rising dose","slug":"biix-1-xx-single-rising-dose","indication":"Other","status":"phase_1"},{"name":"Brotizolam tablet","genericName":"Brotizolam tablet","slug":"brotizolam-tablet","indication":"Other","status":"phase_1"},{"name":"Buscopan®","genericName":"Buscopan®","slug":"buscopan","indication":"Other","status":"marketed"},{"name":"Catapres-TTS-1","genericName":"Catapres-TTS-1","slug":"catapres-tts-1","indication":"Other","status":"marketed"},{"name":"Combivent Respimat via tee adapter","genericName":"Combivent Respimat via tee adapter","slug":"combivent-respimat-via-tee-adapter","indication":"Other","status":"marketed"},{"name":"Dabigatran etexilate pellets","genericName":"Dabigatran etexilate pellets","slug":"dabigatran-etexilate-pellets","indication":"Other","status":"phase_1"},{"name":"Dextromethorphan soft pastilles","genericName":"Dextromethorphan soft pastilles","slug":"dextromethorphan-soft-pastilles","indication":"Other","status":"phase_1"},{"name":"Dextromethorphan syrup - high dose","genericName":"Dextromethorphan syrup - high dose","slug":"dextromethorphan-syrup-high-dose","indication":"Other","status":"phase_1"},{"name":"Duloxetine - low dose","genericName":"Duloxetine - low dose","slug":"duloxetine-low-dose","indication":"Other","status":"marketed"},{"name":"Faldaprevir: 24-week treatment","genericName":"Faldaprevir: 24-week treatment","slug":"faldaprevir-24-week-treatment","indication":"Other","status":"phase_3"},{"name":"Foradil","genericName":"Foradil","slug":"foradil","indication":"Other","status":"marketed"},{"name":"Formoterol 12 mcg","genericName":"Formoterol 12 mcg","slug":"formoterol-12-mcg","indication":"Other","status":"marketed"},{"name":"GIOTRIF 30mg","genericName":"GIOTRIF 30mg","slug":"giotrif-30mg","indication":"Other","status":"phase_2"},{"name":"Ginsana","genericName":"Ginsana","slug":"ginsana","indication":"Other","status":"phase_2"},{"name":"Gladem","genericName":"Gladem","slug":"gladem","indication":"Other","status":"phase_2"},{"name":"Hernexeos","genericName":"ZONGERTINIB","slug":"zongertinib","indication":"Non-squamous NSCLC with HER2 mutations","status":"marketed"},{"name":"High dose of Micardis®, once daily","genericName":"High dose of Micardis®, once daily","slug":"high-dose-of-micardis-once-daily","indication":"Other","status":"marketed"},{"name":"Linagliptin Single Tablet","genericName":"Linagliptin Single Tablet","slug":"linagliptin-single-tablet","indication":"Other","status":"phase_1"},{"name":"Low dose of ritonavir","genericName":"Low dose of ritonavir","slug":"low-dose-of-ritonavir","indication":"Other","status":"phase_1"},{"name":"Merck Glucophage® high dose","genericName":"Merck Glucophage® high dose","slug":"merck-glucophage-high-dose","indication":"Other","status":"phase_1"},{"name":"Metformin hydrochlorid","genericName":"Metformin hydrochlorid","slug":"metformin-hydrochlorid","indication":"Other","status":"marketed"},{"name":"Mexitil","genericName":"MEXILETINE","slug":"mexiletine","indication":"Ventricular Arrhythmias","status":"marketed"},{"name":"Micamlo","genericName":"Micamlo","slug":"micamlo","indication":"Other","status":"phase_2"},{"name":"Other: standard breakfast","genericName":"Other: standard breakfast","slug":"other-standard-breakfast","indication":"Other","status":"phase_1"},{"name":"Pioglitazone 15 mg","genericName":"Pioglitazone 15 mg","slug":"pioglitazone-15-mg","indication":"Other","status":"marketed"},{"name":"Pirfenidoneone","genericName":"Pirfenidoneone","slug":"pirfenidoneone","indication":"Other","status":"phase_2"},{"name":"Pramipexole IR tablet","genericName":"Pramipexole IR tablet","slug":"pramipexole-ir-tablet","indication":"Other","status":"marketed"},{"name":"Prazaxa","genericName":"Prazaxa","slug":"prazaxa","indication":"Other","status":"phase_2"},{"name":"R2: Reference Product Y","genericName":"R2: Reference Product Y","slug":"r2-reference-product-y","indication":"Other","status":"phase_1"},{"name":"Radiolabelled erythromycin","genericName":"Radiolabelled erythromycin","slug":"radiolabelled-erythromycin","indication":"Other","status":"phase_1"},{"name":"Salbutamol sulphate 6 mg","genericName":"Salbutamol sulphate 6 mg","slug":"salbutamol-sulphate-6-mg","indication":"Other","status":"marketed"},{"name":"Salmeterol MDI high","genericName":"Salmeterol MDI high","slug":"salmeterol-mdi-high","indication":"Other","status":"phase_1"},{"name":"Salmeterol capsule - high","genericName":"Salmeterol capsule - high","slug":"salmeterol-capsule-high","indication":"Other","status":"phase_1"},{"name":"Spesolimap","genericName":"Spesolimap","slug":"spesolimap","indication":"Other","status":"phase_1"},{"name":"Spiolto","genericName":"Spiolto","slug":"spiolto","indication":"Other","status":"phase_2"},{"name":"Spiolto® Respimat®","genericName":"Spiolto® Respimat®","slug":"spiolto-respimat","indication":"Other","status":"marketed"},{"name":"Spiriva® Respimat®","genericName":"Spiriva® Respimat®","slug":"spiriva-respimat","indication":"Other","status":"marketed"},{"name":"T3 - High dose of BI 655130","genericName":"T3 - High dose of BI 655130","slug":"t3-high-dose-of-bi-655130","indication":"Other","status":"phase_1"},{"name":"Tiotropium inhalation capsules","genericName":"Tiotropium inhalation capsules","slug":"tiotropium-inhalation-capsules","indication":"Other","status":"marketed"},{"name":"Trazenta","genericName":"Trazenta","slug":"trazenta","indication":"Other","status":"phase_2"},{"name":"Verluma","genericName":"technetium (99mTc) nofetumomab merpentan","slug":"technetium-99mtc-nofetumomab-merpentan","indication":"Nuclear medicine imaging procedure","status":"marketed"},{"name":"[13C]-labeled BI 1584862","genericName":"[13C]-labeled BI 1584862","slug":"13c-labeled-bi-1584862","indication":"Other","status":"phase_1"},{"name":"[14C]-BI 201335 NA radiolabelled drug","genericName":"[14C]-BI 201335 NA radiolabelled drug","slug":"14c-bi-201335-na-radiolabelled-drug","indication":"Other","status":"phase_1"},{"name":"tamsulosin HCl","genericName":"tamsulosin HCl","slug":"tamsulosin-hcl","indication":"Other","status":"marketed"},{"name":"unlabelled hMAb BIWA 4 - high dose","genericName":"unlabelled hMAb BIWA 4 - high dose","slug":"unlabelled-hmab-biwa-4-high-dose","indication":"Other","status":"phase_1"}]},{"name":"Immunology","slug":"immunology","revenue":300000000,"percentOfTotal":2.1,"drugCount":6,"colorKey":"respiratory","drugs":[{"name":"Spevigo","genericName":"SPESOLIMAB","slug":"spesolimab","indication":"Erythrodermic psoriasis","status":"marketed","revenue":300000000},{"name":"CYLTEZO","genericName":"ADALIMUMAB-ADBM","slug":"adalimumab-adbm","indication":"Ankylosing spondylitis","status":"marketed"},{"name":"Mobic","genericName":"MELOXICAM","slug":"meloxicam","indication":"Juvenile rheumatoid arthritis","status":"marketed"},{"name":"SPEVIGO","genericName":"SPESOLIMAB-SBZO","slug":"spesolimab-sbzo","indication":"Erythrodermic psoriasis","status":"marketed"},{"name":"Viramune","genericName":"NEVIRAPINE","slug":"nevirapine","indication":"Human immunodeficiency virus infection","status":"marketed"},{"name":"Viramune","genericName":"Viramune","slug":"viramune","indication":"Human immunodeficiency virus infection","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"metabolic","drugs":[{"name":"Elontril","genericName":"Elontril","slug":"elontril","indication":"Depressive disorder","status":"phase_3"},{"name":"Requip","genericName":"Requip","slug":"requip","indication":"Parkinson's disease","status":"marketed"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"rare","drugs":[{"name":"Praxbind","genericName":"IDARUCIZUMAB","slug":"idarucizumab","indication":"Drug-induced coagulation inhibitor disorder","status":"marketed"}]}],"pipeline":[{"name":"Jardiance","genericName":"empagliflozin","slug":"empagliflozin","phase":"marketed","mechanism":"SYNJARDY combines empagliflozin, which inhibits SGLT2 to increase urinary glucose excretion, and metformin HCl, which improves glucose tolerance and insulin sensitivity.","indications":["Chronic heart failure","Diabetes mellitus type 2"],"catalyst":""},{"name":"Spiriva","genericName":"TIOTROPIUM BROMIDE","slug":"tiotropium-bromide","phase":"marketed","mechanism":"Spiriva works by blocking the action of a chemical called acetylcholine, which causes airway muscles to contract and narrow the airways.","indications":["Asthma","Bronchospasm Prevention with COPD","Chronic Obstructive Pulmonary Disease with Bronchospasms","Chronic bronchitis","Pulmonary emphysema"],"catalyst":""},{"name":"Ofev","genericName":"NINTEDANIB","slug":"nintedanib","phase":"marketed","mechanism":"Ofev works by blocking enzymes that promote fibrosis and tumor growth.","indications":["Idiopathic pulmonary fibrosis","Interstitial fibrosis","Non-small cell lung cancer","Systemic sclerosis associated interstitial lung disease"],"catalyst":""},{"name":"Dabigatran Etexilate","genericName":"DABIGATRAN","slug":"chembl-chembl48361","phase":"marketed","mechanism":"Dabigatran works by directly inhibiting the activity of thrombin, a key enzyme in the blood clotting process.","indications":["Reduction of stroke and systemic embolism risk in non-valvular AF","Treatment of DVT and PE in adults","Reduction of DVT and PE recurrence in adults","Prophylaxis of DVT and PE after hip replacement surgery","Treatment of VTE in pediatric patients"],"catalyst":""},{"name":"Tradjenta","genericName":"LINAGLIPTIN","slug":"linagliptin","phase":"marketed","mechanism":"Tradjenta works by blocking an enzyme that breaks down hormones that help the body release insulin.","indications":["Diabetes mellitus type 2"],"catalyst":""},{"name":"Tradjenta","genericName":"BI 1356","slug":"bi-1356","phase":"marketed","mechanism":"Tradjenta works by blocking the DPP-4 enzyme, which normally breaks down incretin hormones that help regulate blood sugar levels.","indications":["Diabetes mellitus type 2"],"catalyst":""},{"name":"Gilotrif","genericName":"afatinib","slug":"afatinib","phase":"marketed","mechanism":"Gilotrif works by blocking the epidermal growth factor receptor, a protein that helps cancer cells grow.","indications":["Non-small cell lung cancer, positive for epidermal growth factor receptor expression"],"catalyst":""},{"name":"Spevigo","genericName":"SPESOLIMAB","slug":"spesolimab","phase":"marketed","mechanism":"Spevigo works by blocking the interleukin-36 receptor, which plays a key role in the development of psoriasis symptoms.","indications":["Erythrodermic psoriasis","Generalized pustular psoriasis","Pustular psoriasis"],"catalyst":""},{"name":"Pradaxa","genericName":"dabigatran-etexilate","slug":"dabigatran-etexilate","phase":"marketed","mechanism":"Competitive direct thrombin inhibitor preventing fibrin formation and thrombus development.","indications":["Reduction of stroke and systemic embolism risk in non-valvular AF","Treatment of DVT and PE in adults","Reduction of DVT and PE recurrence in adults","Prophylaxis of DVT and PE after hip replacement surgery","Treatment of VTE in pediatric patients"],"catalyst":""},{"name":"Flomax","genericName":"tamsulosin","slug":"tamsulosin","phase":"marketed","mechanism":"5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 7, Alpha-1A adrenergic receptor","indications":["Benign prostatic hyperplasia"],"catalyst":""},{"name":"Actilyse","genericName":"Actilyse","slug":"actilyse","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Aggrenox","genericName":"Aggrenox","slug":"aggrenox","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BI 44847","genericName":"BI 44847","slug":"bi-44847","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Bendrofluazide","genericName":"Bendrofluazide","slug":"bendrofluazide","phase":"marketed","mechanism":"Calcium-activated potassium channel subunit alpha-1, Carbonic anhydrase 1, Carbonic anhydrase 2","indications":["Hypertensive disorder"],"catalyst":""},{"name":"Beromun","genericName":"TASONERMIN","slug":"tasonermin","phase":"marketed","mechanism":"Recombinant protein","indications":["Sarcoma of soft tissue"],"catalyst":""},{"name":"Beta-blockers","genericName":"Beta-blockers","slug":"beta-blockers","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Dabigatran etexilate powder","genericName":"Dabigatran etexilate powder","slug":"dabigatran-etexilate-powder","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"High dose of telmisartan","genericName":"High dose of telmisartan","slug":"high-dose-of-telmisartan","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Maalox","genericName":"Maalox","slug":"maalox","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Praxbind","genericName":"IDARUCIZUMAB","slug":"idarucizumab","phase":"marketed","mechanism":"Idarucizumab reverses dabigatran's anticoagulant effect by binding to it and its metabolites with high affinity.","indications":["Drug-induced coagulation inhibitor disorder"],"catalyst":""},{"name":"T5: Test Product P","genericName":"T5: Test Product P","slug":"t5-test-product-p","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Volasertib, high dose, d1q3w","genericName":"Volasertib, high dose, d1q3w","slug":"volasertib-high-dose-d1q3w","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"WE 941 OD tablets","genericName":"WE 941 OD tablets","slug":"we-941-od-tablets","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ipratropium plus salbutamol UDV","genericName":"ipratropium plus salbutamol UDV","slug":"ipratropium-plus-salbutamol-udv","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"salbutamol UDV","genericName":"salbutamol UDV","slug":"salbutamol-udv","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Amlodipin","genericName":"Amlodipin","slug":"amlodipin","phase":"marketed","mechanism":"Aldehyde oxidase, Voltage-dependent calcium channel gamma-1 subunit, 5-hydroxytryptamine receptor 6","indications":["Angina pectoris","Cerebrovascular accident","Hypertensive disorder","Myocardial Infarction Prevention","Primary Prevention of Coronary Heart Disease"],"catalyst":""},{"name":"Amlodipine 10","genericName":"Amlodipine 10","slug":"amlodipine-10","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Angiotensin-Converting Enzyme Inhibitors","genericName":"Angiotensin-Converting Enzyme Inhibitors","slug":"angiotensin-converting-enzyme-inhibitors","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"B: BI 10773 tablet and metformin tablet","genericName":"B: BI 10773 tablet and metformin tablet","slug":"b-bi-10773-tablet-and-metformin-tablet","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BI 1005273 s.c.","genericName":"BI 1005273 s.c.","slug":"bi-1005273-s-c","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BI 10773 - single rising dose","genericName":"BI 10773 - single rising dose","slug":"bi-10773-single-rising-dose","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BI 11634 IR tablet","genericName":"BI 11634 IR tablet","slug":"bi-11634-ir-tablet","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BI 1387446 200 μg","genericName":"BI 1387446 200 μg","slug":"bi-1387446-200-g","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BI 2536 BS, intravenous","genericName":"BI 2536 BS, intravenous","slug":"bi-2536-bs-intravenous","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BI 3000202_low dose","genericName":"BI 3000202_low dose","slug":"bi-3000202-low-dose","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BI 3032950","genericName":"BI 3032950","slug":"bi-3032950","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BI 3814916","genericName":"BI 3814916","slug":"bi-3814916","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"BI 44370 medium dose","genericName":"BI 44370 medium dose","slug":"bi-44370-medium-dose","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BI 653048 BS H3PO4","genericName":"BI 653048 BS H3PO4","slug":"bi-653048-bs-h3po4","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BI 671800 HEA particulate","genericName":"BI 671800 HEA particulate","slug":"bi-671800-hea-particulate","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BI 690517 formulation 2","genericName":"BI 690517 formulation 2","slug":"bi-690517-formulation-2","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BI 764198 - Formula D","genericName":"BI 764198 - Formula D","slug":"bi-764198-formula-d","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BI 765128","genericName":"BI 765128","slug":"bi-765128","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BI 894999","genericName":"BI 894999","slug":"bi-894999","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BIBV 308 SE solution","genericName":"BIBV 308 SE solution","slug":"bibv-308-se-solution","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BIBW 2948 BS for oral inhalation","genericName":"BIBW 2948 BS for oral inhalation","slug":"bibw-2948-bs-for-oral-inhalation","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BIBW 2992 high dose 6 day","genericName":"BIBW 2992 high dose 6 day","slug":"bibw-2992-high-dose-6-day","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BIBW 2992 plus TMZ","genericName":"BIBW 2992 plus TMZ","slug":"bibw-2992-plus-tmz","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BIBX 245 CL- fasted","genericName":"BIBX 245 CL- fasted","slug":"bibx-245-cl-fasted","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BIIL 284 BS low dose","genericName":"BIIL 284 BS low dose","slug":"biil-284-bs-low-dose","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BIIL 284 BS, low dose, adult patients","genericName":"BIIL 284 BS, low dose, adult patients","slug":"biil-284-bs-low-dose-adult-patients","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BIIX 1 XX - single rising dose","genericName":"BIIX 1 XX - single rising dose","slug":"biix-1-xx-single-rising-dose","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Brotizolam tablet","genericName":"Brotizolam tablet","slug":"brotizolam-tablet","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Buscopan®","genericName":"Buscopan®","slug":"buscopan","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"CYLTEZO","genericName":"ADALIMUMAB-ADBM","slug":"adalimumab-adbm","phase":"marketed","mechanism":"Tumor necrosis factor","indications":["Ankylosing spondylitis","Axial spondyloarthritis","Behcet's disease","Crohn's disease","Hidradenitis suppurativa"],"catalyst":""},{"name":"Catapres-TTS-1","genericName":"Catapres-TTS-1","slug":"catapres-tts-1","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Combivent Respimat via tee adapter","genericName":"Combivent Respimat via tee adapter","slug":"combivent-respimat-via-tee-adapter","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Dabigatran etexilate pellets","genericName":"Dabigatran etexilate pellets","slug":"dabigatran-etexilate-pellets","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Dextromethorphan soft pastilles","genericName":"Dextromethorphan soft pastilles","slug":"dextromethorphan-soft-pastilles","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Dextromethorphan syrup - high dose","genericName":"Dextromethorphan syrup - high dose","slug":"dextromethorphan-syrup-high-dose","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Duloxetine - low dose","genericName":"Duloxetine - low dose","slug":"duloxetine-low-dose","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Elontril","genericName":"Elontril","slug":"elontril","phase":"phase_3","mechanism":"Cytochrome P450 2C19, Neuronal acetylcholine receptor subunit alpha-7, Alpha-1A adrenergic receptor","indications":["Depressive disorder","Major depressive disorder","Nicotine dependence","Obesity","Seasonal affective disorder"],"catalyst":""},{"name":"Faldaprevir: 24-week treatment","genericName":"Faldaprevir: 24-week treatment","slug":"faldaprevir-24-week-treatment","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Fenmetrazina","genericName":"PHENMETRAZINE","slug":"phenmetrazine","phase":"marketed","mechanism":"Sodium-dependent noradrenaline transporter","indications":["Obesity"],"catalyst":""},{"name":"Foradil","genericName":"Foradil","slug":"foradil","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Formoterol 12 mcg","genericName":"Formoterol 12 mcg","slug":"formoterol-12-mcg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GIOTRIF 30mg","genericName":"GIOTRIF 30mg","slug":"giotrif-30mg","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ginsana","genericName":"Ginsana","slug":"ginsana","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Gladem","genericName":"Gladem","slug":"gladem","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Hernexeos","genericName":"ZONGERTINIB","slug":"zongertinib","phase":"marketed","mechanism":"Hernexeos works by blocking the HER2 tyrosine kinase domain, which is a protein that helps cancer cells grow and divide.","indications":["Non-squamous NSCLC with HER2 mutations"],"catalyst":""},{"name":"High dose of Micardis®, once daily","genericName":"High dose of Micardis®, once daily","slug":"high-dose-of-micardis-once-daily","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Jascayd","genericName":"NERANDOMILAST","slug":"nerandomilast","phase":"marketed","mechanism":"Jascayd works by inhibiting the activity of phosphodiesterase 4, an enzyme involved in the inflammatory response.","indications":["Idiopathic Pulmonary Fibrosis","Progressive Pulmonary Fibrosis"],"catalyst":""},{"name":"Linagliptin Single Tablet","genericName":"Linagliptin Single Tablet","slug":"linagliptin-single-tablet","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Low dose of ritonavir","genericName":"Low dose of ritonavir","slug":"low-dose-of-ritonavir","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Merck Glucophage® high dose","genericName":"Merck Glucophage® high dose","slug":"merck-glucophage-high-dose","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Metformin hydrochlorid","genericName":"Metformin hydrochlorid","slug":"metformin-hydrochlorid","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Mexitil","genericName":"MEXILETINE","slug":"mexiletine","phase":"marketed","mechanism":"Mexitil works by blocking abnormal electrical signals in the heart to restore a normal heartbeat.","indications":["Ventricular Arrhythmias"],"catalyst":""},{"name":"Micamlo","genericName":"Micamlo","slug":"micamlo","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Micardis","genericName":"TELMISARTAN","slug":"telmisartan","phase":"marketed","mechanism":"Micardis works by blocking the action of angiotensin II, a hormone that constricts blood vessels and increases blood pressure.","indications":["Hypertension","Cardiovascular Risk Reduction"],"catalyst":""},{"name":"Mobic","genericName":"MELOXICAM","slug":"meloxicam","phase":"marketed","mechanism":"Meloxicam works by inhibiting the enzyme prostaglandin G/H synthase 2, which is involved in the production of prostaglandins that cause pain and inflammation.","indications":["Juvenile rheumatoid arthritis","Osteoarthritis","Rheumatoid arthritis"],"catalyst":""},{"name":"OFEV®","genericName":"OFEV®","slug":"ofev","phase":"marketed","mechanism":"Calcium/calmodulin-dependent protein kinase type IV, Cyclin-dependent kinase 18, Cyclin-dependent kinase-like 2","indications":["Idiopathic pulmonary fibrosis","Interstitial fibrosis","Non-small cell lung cancer","Systemic sclerosis associated interstitial lung disease"],"catalyst":""},{"name":"Other: standard breakfast","genericName":"Other: standard breakfast","slug":"other-standard-breakfast","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Persantin","genericName":"Persantin","slug":"persantin","phase":"phase_1","mechanism":"Equilibrative nucleoside transporter 4, Sodium/nucleoside cotransporter 1, ATP-binding cassette sub-family G member 2","indications":["Atrial fibrillation","Chronic heart failure","Myocardial Perfusion Imaging Adjunct","Platelet Aggregation Inhibition","Prevention of Cerebral Thrombosis"],"catalyst":""},{"name":"Persantine","genericName":"DIPYRIDAMOLE","slug":"dipyridamole","phase":"marketed","mechanism":"Persantine works by inhibiting platelet activation and aggregation by blocking the equilibrative nucleoside transporter 1.","indications":["Atrial fibrillation","Chronic heart failure","Myocardial Perfusion Imaging Adjunct","Platelet Aggregation Inhibition","Prevention of Cerebral Thrombosis"],"catalyst":""},{"name":"Pioglitazone 15 mg","genericName":"Pioglitazone 15 mg","slug":"pioglitazone-15-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Pirfenidoneone","genericName":"Pirfenidoneone","slug":"pirfenidoneone","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Pramipexole IR tablet","genericName":"Pramipexole IR tablet","slug":"pramipexole-ir-tablet","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Prazaxa","genericName":"Prazaxa","slug":"prazaxa","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"R2: Reference Product Y","genericName":"R2: Reference Product Y","slug":"r2-reference-product-y","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Radiolabelled erythromycin","genericName":"Radiolabelled erythromycin","slug":"radiolabelled-erythromycin","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Requip","genericName":"Requip","slug":"requip","phase":"marketed","mechanism":"D(1B) dopamine receptor, D(4) dopamine receptor, 5-hydroxytryptamine receptor 1A","indications":["Parkinson's disease","Restless legs"],"catalyst":""},{"name":"SPEVIGO","genericName":"SPESOLIMAB-SBZO","slug":"spesolimab-sbzo","phase":"marketed","mechanism":"Interleukin-1 receptor-like 2","indications":["Erythrodermic psoriasis","Generalized pustular psoriasis","Pustular psoriasis"],"catalyst":""},{"name":"Salbutamol sulphate 6 mg","genericName":"Salbutamol sulphate 6 mg","slug":"salbutamol-sulphate-6-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Salmeterol MDI high","genericName":"Salmeterol MDI high","slug":"salmeterol-mdi-high","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Salmeterol capsule - high","genericName":"Salmeterol capsule - high","slug":"salmeterol-capsule-high","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Spesolimap","genericName":"Spesolimap","slug":"spesolimap","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Spiolto","genericName":"Spiolto","slug":"spiolto","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Spiolto® Respimat®","genericName":"Spiolto® Respimat®","slug":"spiolto-respimat","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Spiriva® Respimat®","genericName":"Spiriva® Respimat®","slug":"spiriva-respimat","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Striverdi Respimat","genericName":"OLODATEROL","slug":"olodaterol","phase":"marketed","mechanism":"Striverdi Respimat works by stimulating the beta-2 receptors in the lungs to relax airway muscles and improve breathing.","indications":["Chronic obstructive lung disease"],"catalyst":""},{"name":"T3 - High dose of BI 655130","genericName":"T3 - High dose of BI 655130","slug":"t3-high-dose-of-bi-655130","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tiotropium inhalation capsules","genericName":"Tiotropium inhalation capsules","slug":"tiotropium-inhalation-capsules","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Trazenta","genericName":"Trazenta","slug":"trazenta","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Verluma","genericName":"technetium (99mTc) nofetumomab merpentan","slug":"technetium-99mtc-nofetumomab-merpentan","phase":"marketed","mechanism":"","indications":["Nuclear medicine imaging procedure"],"catalyst":""},{"name":"Viramune","genericName":"NEVIRAPINE","slug":"nevirapine","phase":"marketed","mechanism":"Viramune works by binding to the reverse transcriptase enzyme, preventing HIV from replicating.","indications":["Human immunodeficiency virus infection"],"catalyst":""},{"name":"Viramune","genericName":"Viramune","slug":"viramune","phase":"marketed","mechanism":"Gag-Pol polyprotein, Pol polyprotein, Reverse transcriptase","indications":["Human immunodeficiency virus infection"],"catalyst":""},{"name":"[13C]-labeled BI 1584862","genericName":"[13C]-labeled BI 1584862","slug":"13c-labeled-bi-1584862","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"[14C]-BI 201335 NA radiolabelled drug","genericName":"[14C]-BI 201335 NA radiolabelled drug","slug":"14c-bi-201335-na-radiolabelled-drug","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"tamsulosin HCl","genericName":"tamsulosin HCl","slug":"tamsulosin-hcl","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"unlabelled hMAb BIWA 4 - high dose","genericName":"unlabelled hMAb BIWA 4 - high dose","slug":"unlabelled-hmab-biwa-4-high-dose","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[{"date":"2023-03-01","type":"regulatory","headline":"Boehringer Ingelheim Receives FDA Approval for Jardiance","summary":"The FDA approved Jardiance (empagliflozin) for the treatment of type 2 diabetes.","drugName":"Jardiance","sentiment":"positive"},{"date":"2022-02-15","type":"earnings","headline":"Boehringer Ingelheim Reports Strong Earnings Growth","summary":"The company reported strong earnings growth driven by the success of its key products.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE1YcW5URHJhdzRNbXNJYjZZSlU4cVJnRlZUZ1g4dW1lcVFUckVPQWFxNVQydDRlVmtrNGlNZUQ4aFJKMXBXU0dsSXBMRGlFaXFkODF1SjBNZFZEMWVxWjVnRDFLYw?oc=5","date":"2026-03-10","type":"pipeline","source":"Forbes","summary":"Johannes von Baumbach - Forbes","headline":"Johannes von Baumbach","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTFBXanpza040Wms2dzMwVVNJT3dKYkJrZnZneEhMa1VabjBPbmxZd0d4RVFSUm5qbnlRRXQxZnI3V2lud2o5Q2xBblhDZkNvZEVHcEdPUDJHQzRBWmcxSG8wTzVBZw?oc=5","date":"2026-03-10","type":"pipeline","source":"Forbes","summary":"Hubertus von Baumbach - Forbes","headline":"Hubertus von Baumbach","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxOMUJDNTZqOWNWd05Cc1JQTDF0akROak9HdjVBRVFOcXBwTXA5TTBfSzl5V0hsU3NvaVFZWmNqQ1lDdWlyZkcyZTlNWFItd1F0YTA0ZVk4QlY2ZnhrS24waDhKOFQ0VlVqSVRTdlNQUW9NZW5PY25WYWZsRzNSbmRENnhfLW9tVGNRWkxObTltbXlzRHFpZFhFM3QtQ1NTNWVJY1c1U1l0OEVIRE9NNk5xWElQMDdRQ0JPSXlUbWoxUzUzcGM2Sm8tUE1UWmVadk1w?oc=5","date":"2026-02-19","type":"deal","source":"boehringer-ingelheim.com","summary":"Boehringer Ingelheim India and NIPER Raebareli sign MoU to strengthen pharmaceutical education and research collaboration - boehringer-ingelheim.com","headline":"Boehringer Ingelheim India and NIPER Raebareli sign MoU to strengthen pharmaceutical education and research collaboratio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxOOEhLNHhpVGRtS3VZRjMybHB4MlVRN3RYdVdYT05YZ2llWUhMTzFyQlJiQzJXazN1T1dRTEZFNF9uTUJVOXJQQ0EzNkNMWFYyS1RuOWJNVVd1NzFUa2ZkM0owd3JjS0Izb2FLVTNpazM5MDF6Q05LeEpqMEFIU09EX0JBalNWdjlBTGpYbkFNMnlFUDlBLVVkel90Y3ZEUE1EX3k3THpEdEwtczJURkVGUlYtS2lIREN5R1pZcVZWcTJVUzRvdEFnR0J3S3YyWDNRRkwwbXhKQmZwSGc?oc=5","date":"2026-02-19","type":"pipeline","source":"TheCSRUniverse","summary":"Boehringer Ingelheim India and NIPER Raebareli Sign MoU to Strengthen Pharmaceutical Research and Education - TheCSRUniverse","headline":"Boehringer Ingelheim India and NIPER Raebareli Sign MoU to Strengthen Pharmaceutical Research and Education","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-23","type":"deal","source":"Express Pharma","summary":"Viyash Scientific announces partnership with Boehringer Ingelheim to expand companion animal portfolio in India - Express Pharma","headline":"Viyash Scientific announces partnership with Boehringer Ingelheim to expand companion animal portfolio in India","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNY180WHBpRURrTGNVNm52Z2FJZ05QVjlsemJpcVk0QnNBUjBfc3Foc1FKd2cxbkh0NzJfT3FwOThKWEU0ekpSeWxQd2d5MmFOdU83SEFESzQzdmpzYm9xcjB3Y1BHN21nX3RHdEppOEd6WHc4cVFaWW9IOEF0MVBvN3ZkejEwRkZaQUotR2ZueXlFSDF0T2E2R1ZUTUpMV2gyZWZ4SC1qRGtRUEtaa0Y3ekpTeWZVNkdRQ0lwLURfa2N1RXpZR3F3?oc=5","date":"2026-01-22","type":"deal","source":"Business Wire India","summary":"Boehringer Ingelheim India Announces Partnership with Alivira Animal Health Limited - Business Wire India","headline":"Boehringer Ingelheim India Announces Partnership with Alivira Animal Health Limited","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNaDJOeEtrdHZwUzN1VXFlNnFtNWpEZ2pudUk0SWhwQVR2bXkzTHJodDRpNUgxdUtoWENnOW5JMjdtRFgyNEtfMjZFbFhpRFVsREtGQVNJZWU1ZnJQTHU0bmV3WmxHc3JUS1hMY3RGRFNPY193UlJYeHJNQTljeDJHVkJrdW5aOTdzcVpXUjFYTnlSMktsc3V5bjlvUjd6YzBqWmxsYUU4RENuMWZ2czFfTnZseWIyNzRsSEQ4?oc=5","date":"2025-10-23","type":"pipeline","source":"UNILAD","summary":"How world's youngest billionaire you've probably never heard of made his $5,700,000,000 fortune - UNILAD","headline":"How world's youngest billionaire you've probably never heard of made his $5,700,000,000 fortune","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPVkNvNmRMWGdwMmFib0k4WDJlWFcwZnV0Z3VsQUhFdE9VYVhtVVI0OGtPdVhXRzh5R1VJTS1DV3pIVzRjaUZneTZURk9aMlg1MFlyN0d5RXItU2E5RjJUMUoxbzFEQUR0UUhGSGtpdnZYMVpsOXFERC1uakxyMjFhajVzdzdYOG0yS0hReFY4MDNBNWhwOV9LZVFka3dXdmNvWEEwMUdJWkVmUDk0WGMtSGp3?oc=5","date":"2025-08-08","type":"regulatory","source":"Bloomberg.com","summary":"Top German Pharma Boehringer Wins US Approval for Cancer Drug - Bloomberg.com","headline":"Top German Pharma Boehringer Wins US Approval for Cancer Drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQb3FaTG9LLU1vXzI5UkRmeUNheHZ6ckRPUDc3TU84SzVwSTNYb1N0NktUMm9VQU43Qmd2cjQ2WjJkS1R5NFB3YWg3TWtJY3czUTBVbjZqeDRTdFZhU3ZkTU1lUW1rQnVnQWtqNzlNTjlGQzMtSzZOaHRUb1lmTkx6MHNzZXhlZXpSbXNWR2RIc05KVzhvd3lHdHVZWFo0Yng2STNqOG1MdGlob2FkclE?oc=5","date":"2025-04-02","type":"earnings","source":"Fierce Pharma","summary":"Amid uncertainty in the US, Boehringer Ingelheim projects 'slight' revenue increase for '25 - Fierce Pharma","headline":"Amid uncertainty in the US, Boehringer Ingelheim projects 'slight' revenue increase for '25","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1kNUEzU1k1bzExTXEzTVpxYmlqZ2hHTk9TWmFac1o5Y0twUHJuQ09BMDA4bjRSQmtINUJXUXJTNTFPTzN6aEh5b1dJYkpCMHBZNFViUWdPek5QUGxHQmRuanBjaGswYmc?oc=5","date":"2024-12-20","type":"pipeline","source":"Built In","summary":"20 Pharmaceutical Companies in Germany to Know - Built In","headline":"20 Pharmaceutical Companies in Germany to Know","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPVDFrdUpNT2lJWVh6ZloxX0lXaFBXSkVrNUVQZzY3YnF6WlpSV1AxSUREQXBlZnZFLUVXNHFyZlNSUG1rRWlwMnJUaXJxRjFxYkdUY0ZIZjdyMWtyRXd3TU9rUEN0XzFXWE9XaXFNQVp0UjNGaVdLMUdXaUhtd1FEZmRNLUFSSGFwX3o2UVBQNUFRYndnRXVKdGpYNXNrLWoycDNIblZXeE5fc0tMcFVSeWU2TFA3WC1mUlpzdnQtQ0llR1JCYVhsaVhNR2lBTmxCMkVtV2tqSGp2cmxhMHhVdmE1MUU0SV9RblE?oc=5","date":"2024-05-13","type":"patent","source":"PR Newswire","summary":"Boehringer Ingelheim expands access to adalimumab-adbm injection, the company's biosimilar to Humira® - PR Newswire","headline":"Boehringer Ingelheim expands access to adalimumab-adbm injection, the company's biosimilar to Humira®","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOY2dLX0hwSWlGQ014RERSN0ctRGxEemtyMVVxNmRZWWpuX3l2MEw5ak8teXA3c19BckZmV0xHdXk0U1FsdlV2Vm1RcVU3OGFXTnJNemxVcGZIWWdBV01lT0lLZ1BTZFlINkdsNXNfOEE1NU5oZVZxb1FQRkNlYzd5TGgyU2VQbUh3V3BzTFplakVYbW9kamhMSFF3eUR4UFNhSnJPeWFyVdIBrAFBVV95cUxNaENCbWV3dS1zUWcxM0QxMlZPODFrTEVwd3ZSa0hienNVTGRIRm1pNmRzWTlad0l5MVVCODRtOEVOSG01ci1SV291TE5NQWhtVENWRUxPaDBRYm1namxMb3Q2TXVaZGRyaS1jT2xNaUNMeWVZeXJKZ0ZfR29YLXEtb2xvM2dERkU4dnlsMmVGZ0czYzlNRG9JWHk5dkswSnhSR3BybFNVLUhpZnQ1?oc=5","date":"2024-01-17","type":"pipeline","source":"CNBC","summary":"The weight loss drug market may soon get more crowded. Here are the companies trying to enter the booming space - CNBC","headline":"The weight loss drug market may soon get more crowded. Here are the companies trying to enter the booming space","sentiment":"neutral"}],"patents":[{"drugName":"Spiriva","drugSlug":"tiotropium-bromide","patentNumber":"7396341","type":"Formulation","expiryDate":"2026-10-10","territory":"US","annualRevenue":2500000000,"genericFilings":[]},{"drugName":"Spiriva","drugSlug":"tiotropium-bromide","patentNumber":"9027967","type":"Formulation","expiryDate":"2027-03-31","territory":"US","annualRevenue":2500000000,"genericFilings":[]},{"drugName":"Spiriva","drugSlug":"tiotropium-bromide","patentNumber":"7396341*PED","type":"Compound","expiryDate":"2027-04-10","territory":"US","annualRevenue":2500000000,"genericFilings":[]},{"drugName":"Spiriva","drugSlug":"tiotropium-bromide","patentNumber":"9027967*PED","type":"Compound","expiryDate":"2027-09-30","territory":"US","annualRevenue":2500000000,"genericFilings":[]},{"drugName":"Spiriva","drugSlug":"tiotropium-bromide","patentNumber":"7837235","type":"Formulation","expiryDate":"2028-03-13","territory":"US","annualRevenue":2500000000,"genericFilings":[]},{"drugName":"Spiriva","drugSlug":"tiotropium-bromide","patentNumber":"7837235*PED","type":"Compound","expiryDate":"2028-09-13","territory":"US","annualRevenue":2500000000,"genericFilings":[]},{"drugName":"Viramune","drugSlug":"nevirapine","patentNumber":"8460704","type":"Method of Use","expiryDate":"2029-03-12","territory":"US","genericFilings":[]},{"drugName":"Mobic","drugSlug":"meloxicam","patentNumber":"10709713","type":"Method of Use","expiryDate":"2030-05-26","territory":"US","genericFilings":[]},{"drugName":"Mobic","drugSlug":"meloxicam","patentNumber":"11253478","type":"Formulation","expiryDate":"2030-05-26","territory":"US","genericFilings":[]},{"drugName":"Mobic","drugSlug":"meloxicam","patentNumber":"9974746","type":"Formulation","expiryDate":"2030-05-26","territory":"US","genericFilings":[]},{"drugName":"Jardiance","drugSlug":"empagliflozin","patentNumber":"","type":"Patent Cliff","expiryDate":"2030-06-01","territory":"US","annualRevenue":1500000000},{"drugName":"Mobic","drugSlug":"meloxicam","patentNumber":"8545879","type":"Formulation","expiryDate":"2030-08-31","territory":"US","genericFilings":[]},{"drugName":"Spiriva","drugSlug":"tiotropium-bromide","patentNumber":"8733341","type":"Formulation","expiryDate":"2030-10-16","territory":"US","annualRevenue":2500000000,"genericFilings":[]},{"drugName":"Spiriva","drugSlug":"tiotropium-bromide","patentNumber":"8733341*PED","type":"Compound","expiryDate":"2031-04-16","territory":"US","annualRevenue":2500000000,"genericFilings":[]},{"drugName":"Mobic","drugSlug":"meloxicam","patentNumber":"9526734","type":"Formulation","expiryDate":"2033-03-31","territory":"US","genericFilings":[]},{"drugName":"Mobic","drugSlug":"meloxicam","patentNumber":"9808468","type":"Method of Use","expiryDate":"2035-03-31","territory":"US","genericFilings":[]},{"drugName":"Mobic","drugSlug":"meloxicam","patentNumber":"9649318","type":"Formulation","expiryDate":"2035-03-31","territory":"US","genericFilings":[]},{"drugName":"Mobic","drugSlug":"meloxicam","patentNumber":"11458145","type":"Method of Use","expiryDate":"2039-03-08","territory":"US","genericFilings":[]},{"drugName":"Mobic","drugSlug":"meloxicam","patentNumber":"10881663","type":"Method of Use","expiryDate":"2039-03-08","territory":"US","genericFilings":[]},{"drugName":"Mobic","drugSlug":"meloxicam","patentNumber":"12059423","type":"Compound","expiryDate":"2040-07-19","territory":"US","genericFilings":[]},{"drugName":"Mobic","drugSlug":"meloxicam","patentNumber":"12263176","type":"Formulation","expiryDate":"2041-07-31","territory":"US","genericFilings":[]}],"drugCount":110,"phaseCounts":{"marketed":53,"discontinued":1,"phase_1":44,"phase_2":10,"phase_3":2},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Novo Nordisk","Sanofi","Eli Lilly"],"therapeuticFocus":["Diabetes","Respiratory","Oncology"],"financials":null,"yahoo":null}